Cholangiocarcinoma risk factors and the potential role of aspirin

Fabio Bagante^{1

2}, T Clark Gamblin³, Timothy M Pawlik¹

Affiliations

¹ Division of Surgical Oncology, Department of Surgery, Johns Hopkins Hospital, Baltimore, MD.
² Department of Surgery, University of Verona, Verona, Italy.
³ Department of Surgery, Medical College of Wisconsin, Milwaukee, WI.

Editorial

Fabio Bagante et al. Hepatology. 2016 Sep.

. 2016 Sep;64(3):708-10.

doi: 10.1002/hep.28613. Epub 2016 May 28.

Fabio Bagante^{1

2}, T Clark Gamblin³, Timothy M Pawlik¹

¹ Division of Surgical Oncology, Department of Surgery, Johns Hopkins Hospital, Baltimore, MD.
² Department of Surgery, University of Verona, Verona, Italy.
³ Department of Surgery, Medical College of Wisconsin, Milwaukee, WI.

No abstract available

Comment on

Aspirin use and the risk of cholangiocarcinoma.
Choi J, Ghoz HM, Peeraphatdit T, Baichoo E, Addissie BD, Harmsen WS, Therneau TM, Olson JE, Chaiteerakij R, Roberts LR. Choi J, et al. Hepatology. 2016 Sep;64(3):785-96. doi: 10.1002/hep.28529. Epub 2016 Apr 26. Hepatology. 2016. PMID: 26940227 Free PMC article.